Browse our extensive catalog of high-quality chemicals for research and development.
| Product Name | Description | CAS Number | Molecular Formula | Molecular Weight | Description |
|---|---|---|---|---|---|
| Lamivudine Tenofovir Monosoproxil Methane | ((Hydroxy((((R)-1-(6-((((1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)amino)methyl)amino)-9H-purin-9-yl)propan-2-yl)oxy)methyl)phosphoryl)oxy)methyl Isopropyl Carbonate | NA | C23H33N8O10PS | 644.59 | ((Hydroxy((((R)-1-(6-((((1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)amino)methyl)amino)-9H-purin-9-yl)propan-2... |
| Lamivudine Acid | (2R-cis)-5-(4-amino-2-oxo-1(2H)-pyrimidinyl)-1,3-oxathiolane-2-carboxylic Acid; Lamivudine EP Impurity A | 173829-09-9 | C8H9N3O4S | 243.24 | (2R-cis)-5-(4-amino-2-oxo-1(2H)-pyrimidinyl)-1,3-oxathiolane-2-carboxylic Acid; Lamivudine EP Impurity A |
| Lamivudine Acid-13C,15N2 | (2R-cis)-5-(4-amino-2-oxo-1(2H)-pyrimidinyl)-1,3-oxathiolane-2-carboxylic Acid-13C,15N2; | 1391052-30-4 | C7 13 CH9N 15 N2O4S | 246.22 | (2R-cis)-5-(4-amino-2-oxo-1(2H)-pyrimidinyl)-1,3-oxathiolane-2-carboxylic Acid-13C,15N2; |
| Lamivudine | 4-Amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-2(1H)-pyrimidinone; (2R-cis)-4-Amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-2(1H)-pyrimidinone; (-)-2’-Deoxy-3’-thiacytidine; (-)-BCH 189; 3TC; Epivir HBV; Hepitec; Heptodin; Heptovir; L-SddC; Lamivir; Virolam; Zeffix; beta-L-2’,3’-Dideoxy-3’-thiacytidine; beta-L-3’-Thia-2’,3’-dideoxycytidine | 134678-17-4 | C8H11N3O3S | 229.26 | 4-Amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-2(1H)-pyrimidinone; (2R-cis)-4-Amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-2(1H)-pyrimi... |
| Lamivudine-15N2,13C | 4-Amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-2(1H)-pyrimidinone-15N2,13C; (2R-cis)-4-Amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-2(1H)-pyrimidinone-15N2,13C; (-)-2’-Deoxy-3’-thiacytidine-15N2,13C; (-)-BCH 189-15N2,13C; 3TC-15N2,13C; Epivir HBV-15N2,13C; Hepitec-15N2,13C; Heptodin-15N2,13C; Heptovir-15N2,13C; L-SddC-15N2,13C; Lamivir-15N2,13C; Virolam-15N2,13C; Zeffix-15N2,13C; beta-L-2’,3’-Dideoxy-3’-thiacytidine-15N2,13C; beta-L-3’-Thia-2’,3’-dideoxycytidine-15N2,13C | 1217746-03-6 | C7 13CH11N 15 N2O3S | 232.24 | 4-Amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-2(1H)-pyrimidinone-15N2,13C; (2R-cis)-4-Amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-2(1... |
| Lamivudine-13C1,d2 | 4-Amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-2(1H)-pyrimidinone-13C1,d2; (2R-cis)-4-Amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-2(1H)-pyrimidinone-13C1,d2; (-)-2’-Deoxy-3’-thiacytidine-13C1,d2; (-)-BCH 189-13C1,d2; 3TC-13C1,d2; Epivir HBV-13C1,d2; Hepitec-13C1,d2; Heptodin-13C1,d2; Heptovir-13C1,d2; L-SddC-13C1,d2; Lamivir-13C1,d2; Virolam-13C1,d2; Zeffix-13C1,d2; beta-L-2’,3’-Dideoxy-3’-thiacytidine-13C1,d2; beta-L-3’-Thia-2’,3’-dideoxycytidine-13C1,d2 | NA | C7 13 CH9D2N3O3S | 232.26 | 4-Amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-2(1H)-pyrimidinone-13C1,d2; (2R-cis)-4-Amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-2(1H... |
| 1,4-Bis(3-(2-(trifluoromethyl)-10H-phenothiazin-10-yl)propyl)piperazine | Fluphenazine Impurity D (EP) | C36H34F6N4S2 | 700.8 | Fluphenazine Impurity D (EP)
| |
| 1,4-Bis(3-(2-(trifluoromethyl)-10H-phenothiazin-10-yl)propyl)piperazine-d8 | Fluphenazine Impurity D-d8 (EP) | C36H26D8F6N4S2 | 708.85 | Fluphenazine Impurity D-d8 (EP)
| |
| 1,2-Bis(2,3,5,6-tetrabromophenyl)ethane | 2,2,3,3,5,5,6,6-Octabromo-bibenzyl | C14H6Br8 | 813.43 | 2,2,3,3,5,5,6,6-Octabromo-bibenzyl
| |
| 4,4-Bis(trimethylacetoxy)benzophenone | 2,2-Dimethyl-propanoic Acid 4-[4-(2,2-Dimethyl-1-oxopropoxy)benzoyl]phenyl Ester; | 112004-83-8 | C23H26O5 | 382.45 | 2,2-Dimethyl-propanoic Acid 4-[4-(2,2-Dimethyl-1-oxopropoxy)benzoyl]phenyl Ester;
|
Page 967 of 10017